Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor
- *Howard Hughes Medical Institute and †Departments of Biochemistry and Molecular Biology, Oregon Health Sciences University, Portland, OR 97201; and ‡Division of Cardiovascular Medicine, Stanford University Medical School, Stanford, CA 94305
-
Communicated by Richard N. Zare, Stanford University, Stanford, CA (received for review January 8, 2001)
Abstract
The majority of extracellular physiologic signaling molecules act by stimulating GTP-binding protein (G-protein)-coupled receptors (GPCRs). To monitor directly the formation of the active state of a prototypical GPCR, we devised a method to site specifically attach fluorescein to an endogenous cysteine (Cys-265) at the cytoplasmic end of transmembrane 6 (TM6) of the β2 adrenergic receptor (β2AR), adjacent to the G-protein-coupling domain. We demonstrate that this tag reports agonist-induced conformational changes in the receptor, with agonists causing a decline in the fluorescence intensity of fluorescein-β2AR that is proportional to the biological efficacy of the agonist. We also find that agonists alter the interaction between the fluorescein at Cys-265 and fluorescence-quenching reagents localized to different molecular environments of the receptor. These observations are consistent with a rotation and/or tilting of TM6 on agonist activation. Our studies, when compared with studies of activation in rhodopsin, indicate a general mechanism for GPCR activation; however, a notable difference is the relatively slow kinetics of the conformational changes in the β2AR, which may reflect the different energetics of activation by diffusible ligands.
Footnotes
-
↵ § To whom reprint requests should be addressed at: Howard Hughes Medical Institute, B-157, Beckman Center, Stanford University Medical School, Stanford, CA 94305-5428. E-mail: kobilka{at}cmgm.stanford.edu.
- Abbreviations:
- G protein,
- GTP-binding protein;
- β2AR,
- β2 adrenergic receptor;
- TM,
- transmembrane;
- ISO,
- (−)-isoproterenol;
- ALP,
- (−)-alprenolol;
- NHS,
- N-hydroxysuccinimide;
- 5-DOX,
- 5-doxyl stearate;
- CAT-16,
- 4-(N,N-dimethyl-N-hexadecyl)ammonium-2,2,6,6-tetramethylpiperidine-1-oxyl iodide;
- GPCR,
- G-protein-coupled receptor
- Copyright © 2001, The National Academy of Sciences





